Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04357184 · ClinicalTrials.gov registry record · NA
BFRT for Severe Lower Extremity Muscle Atrophy
A NA study, sponsored by Cincinnati Sportsmedicine Research and Education Foundation.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT04357184: Completed NA study, sponsored by Cincinnati Sportsmedicine Research and Education Foundation.
NCT04357184 is a NA study that has completed, run by Cincinnati Sportsmedicine Research and Education Foundation. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04357184, a NA study, has completed, sponsored by Cincinnati Sportsmedicine Research and Education Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Muscle weakness or atrophy is a common condition following acute and chronic musculoskeletal injuries. Strength training is an imperative component in clinical rehabilitation of musculoskeletal injuries. Heavy exercise loads (approximately 70% of one repetition maximum) is necessary to elicit muscle hypertrophy and strength gains. However, patients with severe muscle atrophy are frequently unable to tolerate these loads due to pain. Blood flow resistance training with low resistance loads may be used to safely develop muscle strength.
Primary Outcome
Isometric knee flexor and extensor strength will be measured with an isokinetic dynamometer before training and after each series of 9 training sessions
Interventions
- OTHER Blood flow restriction training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-04-14 |
| Est. Completion | 2022-02-15 |
| Phase | NA |
What the finished NCT04357184 record still lists
NCT04357184 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Blood flow restriction training is the first listed.
NCT04357184 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04357184 about?
NCT04357184 is a clinical study titled "BFRT for Severe Lower Extremity Muscle Atrophy". Muscle weakness or atrophy is a common condition following acute and chronic musculoskeletal injuries. Strength training is an imperative component in clinical rehabilitation of musculoskeletal injuries. Heavy exercise loads (approximately 70% of one repetition maximum) is necessary to elicit muscle...
What is the current status of trial NCT04357184?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2020-04-14. Estimated completion is 2022-02-15.
What interventions are being tested in trial NCT04357184?
The interventions under investigation include: Blood flow restriction training (OTHER).
Who is sponsoring clinical trial NCT04357184?
This trial is sponsored by Cincinnati Sportsmedicine Research and Education Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04357184's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI